Treato

Patients are increasingly taking an active role in their healthcare. The Internet has not only given consumers and patients a place to get information and conduct research. It’s given them a place to tell their story.
Treato automatically collects, indexes and analyzes the massive amount of content patients and caregivers generate online to extract relevant information, connect the dots and create the big picture of what they are saying about their personal treatment- and condition-related experiences. The result is the world’s largest source of patient insights gathered from billions of online conversations across the social web. We call it the patient voice.

For the first time, the social health web has been indexed on such a massive scale to generate the voice of the patient about patients’ collective, real world health and treatment experiences. This information is driving change in healthcare by providing a new source of data to support healthcare decision making for patients and industry stakeholders alike. We‘re doing this in one of two ways:

Treato.com: Our free, online portal offers patients a single online destination for accessing the collective patient voice from across the Internet. More than 2-3 million patients and caregivers around the world access Treato.com every month to find out what other patients are saying their symptoms, conditions and available treatment.

Treato IQ: Our patient intelligence platform helps companies understand the “why” and “what” behind what patients are saying to drive key decisions throughout the brand lifecycle. A range of available solutions provide real time, actionable patient insights about all brands and conditions to align with highly targeted strategic pharmaceutical marketing and business goals.


Schedule a meeting



1 2 3
Upload your CV
Files uploaded
Sending! Continue:

Thank you for sending us your CV!

In the next few days, Join's evaluation team will review your application and supply you with potential opportunities. We'd love to hear from you through , .
We welcome your questions and continued feedback